Clinical trial
Immune Therapies and Anti-HIV Therapy Withdrawal in Controlling Viral Load
NCT00013663 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00013663 |
|---|---|
| Title | Immune Therapies and Anti-HIV Therapy Withdrawal in Controlling Viral Load |
| Official title | A Randomized Controlled Study Testing the Efficacy of Immunotherapies to Control Plasma HIV RNA Concentrations Upon Interruption of Highly Active Antiretroviral Therapy |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Collaborators | New York Presbyterian Hospital |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Biological, Drug |
| Interventions | ALVAC(2)120(B, MN)GNP (vCP1452), Aldesleukin |
| Enrollment | 92 |
| Completion | Jun 1, 2006 |
| First posted | Aug 31, 2001 |
| Last update posted | Nov 2, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: